Emaciation: Clinical Trials

4 trials for Emaciation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 withdrawn. 2 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 41Withdrawn 1

Follow Emaciation: new trials by email Literature Review of Emaciation trials Research Report on Emaciation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Energy Metabolism for the Patients With Pulmonary Mycobacterium Avium Complex
Pulmonary MAC, Energy Metabolism
CompletedNational Hospital Organization Minami Kyoto Hospital1052018-05-012021-12-28
Clinical Study of BYM338 for the Treatment of Unintentional Weight Loss in Patients With Cancer of the Lung or the Pancreas
BYM338 active drug, Placebo - Cachexia
Phase 2CompletedNovartis Pharmaceuticals572011-08-012016-03-02
Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss
Megestrol acetate oral suspension nanocrystal dispersion 115 mg/mL, Megestrol acetate oral suspension 40 mg/mL - HIV Infections, Cachexia
Phase 2CompletedEndo USA Inc., a Keenova Therapeutics Company632004-12-012017-10-05
Clinical Trial to Determine the Efficacy of Sculptra™ Dermal Filler for the Correction of Contour Deformities Caused by Lipoatrophy
Sculptra Injection - Lipodystrophy, Emaciation
Phase 4WithdrawnDermatology Cosmetic Laser Medical Associates of La Jolla, Inc.152007-08-21

Narrower conditions

Cachexia (2)  ·  Adenocarcinoma (1)  ·  Anorexia (1)  ·  Body Weight Changes (1)  ·  Facies (1)  ·  HIV Infections (1)  ·  HIV Wasting Syndrome (1)  ·  Lipodystrophy (1)  ·  Lung Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Wasting Syndrome (1)  ·  Weight Loss (1)

Broader conditions

Body Weight (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (4)  ·  Thinness (4)  ·  Metabolic Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Nutrition Disorders (2)  ·  Blood-Borne Infections (1)  ·  Body Weight Changes (1)  ·  Carcinoma (1)  ·  Communicable Diseases (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Disease Attributes (1)  ·  Endocrine Gland Neoplasms (1)

Interventions

Megestrol Acetate (1)

Sponsors

Dermatology Cosmetic Laser Medical Associates of La Jolla, Inc. (1)  ·  Endo USA Inc., a Keenova Therapeutics Company (1)  ·  National Hospital Organization Minami Kyoto Hospital (1)  ·  Novartis Pharmaceuticals (1)

Countries

United States (3)  ·  India (1)  ·  Japan (1)  ·  Lithuania (1)  ·  Romania (1)  ·  South Africa (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Jan Fourie, MD (1)  ·  Mitchel P. Goldman, M.D. (1)

Results publications

PMID 39007915